Targeting the Epigenome for the Treatment and Prevention of Lung Cancer

This publication has 135 references indexed in Scilit:

• Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates
  Biochemical and Biophysical Research Communications, 2004
• Hypermethylation ofRASSF1AandBLUtumor suppressor genes in non‐small cell lung cancer: Implications for tobacco smoking during adolescence
  International Journal of Cancer, 2004
• Differential protein acetylation induced by novel histone deacetylase inhibitors
  Biochemical and Biophysical Research Communications, 2004
• Specific and Redundant Functions of Histone Deacetylases in Regulation of Cell Cycle and Apoptosis
  Cell Cycle, 2004
• Histone deacetylase inhibitors specifically kill nonproliferating tumour cells
  Oncogene, 2004
• The history of cancer epigenetics
  Nature Reviews Cancer, 2004
• Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small‐cell lung cancer lines and drug‐resistant sublines
  International Journal of Cancer, 2003
• Zebularine: A Novel DNA Methylation Inhibitor that Forms a Covalent Complex with DNA Methyltransferases
  Journal of Molecular Biology, 2002
• The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14ARF, p16INK4a and RASSF1A in human lung cancer cell lines
  Oncogene, 2002
• DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
  Nature, 2002